Work

The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials

Year: 2020
Type: review
Abstract: Introduction: Statins may reduce the severity of psoriasis, but the available evidence is unclear.We conducted a meta-analysis of randomized controlled studies (RCTs) that investigated the effect of statins on psoriasis severity assessed with the Psoriasis Area and Severity Index (PASI).Material and methods: Two investigators searched independently the following databases: Medline, EMBASE, Cochrane Central Register of Controlled Trials and ClinicalTrials.govfrom inception to February 2019.Additionally, reference lists from all available articles were searched manually.We included only RCTs carried out among adult (≥ 16 years) patients with psoriasis who received oral statins for ≥ 8 weeks and had psoriasis severity assessed with the PASI at baseline and at the end of follow-up.We used random effects meta-analysis to calculate the mean difference (D) in PASI change between patients who received either a statin or a comparator.Results: Of 279 records identified, there were 5 eligible RCTs, with a total of 223 patients, including 128 patients who received a statin (atorvastatin or simvastatin).The improvement in psoriasis severity (PASI) was significantly greater in patients who received statins than in those who received comparators (D = 2.76, 95% CI: 0.49-5.04,p = 0.017).In subgroup analyses, the improvement in PASI values was significant for simvastatin (D = 3.70, 95% CI: 2.52-4.89,p < 0.001) but not for atorvastatin (D = 2.30, 95% CI: -1.28-5.88,p = 0.210).Conclusions: Oral statins may improve psoriasis, particularly in patients with severe disease.This observation should be verified in long-term, well-designed studies that will enable analyses adjusted for clinical variables.
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $1,078
OpenAlex ID: W2998982231
FWCI: 0.72
Cites: 43
Cited by: 68
Related to: 10